Teladoc Health, Inc. Stock Deutsche Boerse AG
Equities
4LL
US87918A1051
Healthcare Facilities & Services
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.795 EUR | -1.25% | -2.29% | -50.80% |
Jun. 10 | Teladoc Health, Inc. Announces Chief Executive Office Changes | CI |
Jun. 10 | Teladoc Health, Inc. Appoints Charles Divita, III as Director | CI |
Sales 2024 * | 2.66B 2.48B | Sales 2025 * | 2.76B 2.57B | Capitalization | 1.81B 1.69B |
---|---|---|---|---|---|
Net income 2024 * | -177M -165M | Net income 2025 * | -110M -103M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 297M 277M | Net Debt 2025 * | 61.18M 57.03M | EV / Sales 2025 * | 0.68 x |
P/E ratio 2024 * |
-9.97
x | P/E ratio 2025 * |
-15.9
x | Employees | 5,208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.19% |
Latest transcript on Teladoc Health, Inc.
1 day | -1.25% | ||
1 week | -2.29% | ||
Current month | -5.03% | ||
1 month | -15.08% | ||
3 months | -31.78% | ||
6 months | -44.15% | ||
Current year | -50.80% |
Managers | Title | Age | Since |
---|---|---|---|
Mala Murthy
DFI | Director of Finance/CFO | 60 | 19-06-23 |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 11-01-31 |
Nikolaos Nanis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Snow
CHM | Chairman | 69 | 14-01-31 |
Sandra Fenwick
BRD | Director/Board Member | 73 | 20-11-18 |
David Shedlarz
BRD | Director/Board Member | 75 | 16-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 9.769 | -1.51% | 120 |
24-06-10 | 9.919 | +0.19% | 216 |
24-06-07 | 9.9 | -0.93% | 3,310 |
24-06-06 | 9.993 | -0.09% | 146 |
24-06-05 | 10 | +0.04% | 473 |
Delayed Quote Deutsche Boerse AG, June 11, 2024 at 09:55 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+139.66% | 4.64B | |
+78.57% | 584M | |
+1.77% | 443M | |
-73.62% | 122M | |
-33.67% | 96.08M |
- Stock Market
- Equities
- TDOC Stock
- 4LL Stock